Deployment of convalescent plasma for the prevention and treatment of COVID-19

Severe acute respiratory syndrome coronavirus 2 (SARS–CoV-2), the cause of coronavirus disease 2019 (COVID-19), has spurred a global health crisis. To date, there are no proven options for prophylaxis for those who have been exposed to SARS–CoV-2, nor therapy for those who develop COVID-19. Immune (...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:J Clin Invest
Main Authors: Bloch, Evan M., Shoham, Shmuel, Casadevall, Arturo, Sachais, Bruce S., Shaz, Beth, Winters, Jeffrey L., van Buskirk, Camille, Grossman, Brenda J., Joyner, Michael, Henderson, Jeffrey P., Pekosz, Andrew, Lau, Bryan, Wesolowski, Amy, Katz, Louis, Shan, Hua, Auwaerter, Paul G., Thomas, David, Sullivan, David J., Paneth, Nigel, Gehrie, Eric, Spitalnik, Steven, Hod, Eldad A., Pollack, Lewis, Nicholson, Wayne T., Pirofski, Liise-anne, Bailey, Jeffrey A., Tobian, Aaron A.R.
Formato: Artigo
Idioma:Inglês
Publicado em: American Society for Clinical Investigation 2020
Assuntos:
Review
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC7259988/
https://ncbi.nlm.nih.gov/pubmed/32254064
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1172/JCI138745
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados